首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Investigation on antineoplastic potential of Barleria lupulina Lindl: From phytochemical profiling to molecular dynamics simulation assessment 狼疮芽孢杆菌抗肿瘤潜能的研究:从植物化学谱分析到分子动力学模拟评价
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-30 DOI: 10.1016/j.jaim.2025.101220
Sabyasachi Banerjee , Avik Das , Sankhadip Bose , Subhasis Banerjee , Anusha Bishayee , Anupam Bishayee

Background

Barleria lupulina, a medicinal plant of India, South China and Southeast Asia, is known for its antioxidant and cytotoxic abilities. Although this plant has shown significant promise as an anticancer agent, the underlying mechanisms of action are yet to be explored. Objective: This study aimed to assess antiproliferative and proapoptotic potential of B. lupulina leaf extract with understanding of cellular and molecular mechanisms.

Materials and methods

The ethanolic extract was characterized using liquid chromatography-mass spectrometry and its anticancer activity was then assessed against Caco-2 colon cancer and A549 lung cancer cell lines.

Results

Phytochemical analysis of the extract revealed the presence of acetylbarlerin, decaffeoylacteoside, gallic acid, ipolamiide, leonuriside A, shanzhiside, and vanillic acid. The extract showed concentration-dependent cytotoxicity against both cancer cells. It induced early apoptosis at lower concentrations and late apoptosis at higher concentrations. Moreover, the extract noticeably reduced reactive oxygen species and mitochondrial membrane potential in a concentration-dependent way. The Western blot and quantitative reverse transcription polymerase chain reaction showed upregulation of Bax, caspase-8, caspase-9, and cluster of differentiation 95, and downregulation of Bcl-2. Molecular docking studies revealed that decaffeoylacteoside, gallic acid, and vanillic acid exhibited dual affinities for both caspase-8 and caspase-9, while acetylbarlerin, ipolamiide, leonuriside A, and shanzhiside showed selective affinities only for caspase-9.

Conclusion

The ethanolic leaf extract shows significant cytotoxic and proapoptotic activities, confirming its potential as a useful resource of bioactive compounds against cancer. Nevertheless, more in-depth investigations are necessary to realize the full potential of this medicinal plant for cancer therapy.
狼疮barleria lupina是印度、华南和东南亚的一种药用植物,以其抗氧化和细胞毒性而闻名。虽然这种植物已经显示出作为抗癌剂的重要前景,但其潜在的作用机制还有待探索。目的:研究狼疮叶提取物的抗增殖和促凋亡作用,探讨其细胞和分子机制。材料与方法采用液相色谱-质谱联用技术对乙醇提取物进行了表征,并对Caco-2结肠癌和A549肺癌细胞株进行了抑癌活性评价。结果植物化学分析显示,提取物中含有乙酰巴勒蛋白、脱咖啡因酰乳糖苷、没食子酸、异丙酰胺、枸橼酸苷A、山芝苷和香草酸。提取物对两种癌细胞的细胞毒性均呈浓度依赖性。低浓度诱导早期细胞凋亡,高浓度诱导晚期细胞凋亡。此外,提取物以浓度依赖性的方式显著降低活性氧和线粒体膜电位。Western blot和定量逆转录聚合酶链反应显示Bax、caspase-8、caspase-9、cluster of differentiation 95表达上调,Bcl-2表达下调。分子对接研究发现,脱咖啡酰乳糖苷、没食子酸和香草酸对caspase-8和caspase-9具有双重亲和力,而乙酰barlerin、ipolamide、leonuriside A和山芝苷仅对caspase-9具有选择性亲和力。结论乙醇提取物具有显著的细胞毒活性和促凋亡活性,具有开发抗癌活性物质的潜力。然而,为了充分发挥这种药用植物治疗癌症的潜力,还需要进行更深入的研究。
{"title":"Investigation on antineoplastic potential of Barleria lupulina Lindl: From phytochemical profiling to molecular dynamics simulation assessment","authors":"Sabyasachi Banerjee ,&nbsp;Avik Das ,&nbsp;Sankhadip Bose ,&nbsp;Subhasis Banerjee ,&nbsp;Anusha Bishayee ,&nbsp;Anupam Bishayee","doi":"10.1016/j.jaim.2025.101220","DOIUrl":"10.1016/j.jaim.2025.101220","url":null,"abstract":"<div><h3>Background</h3><div><em>Barleria lupulina</em>, a medicinal plant of India, South China and Southeast Asia, is known for its antioxidant and cytotoxic abilities. Although this plant has shown significant promise as an anticancer agent, the underlying mechanisms of action are yet to be explored. <em><strong>Objective</strong></em><strong>:</strong> This study aimed to assess antiproliferative and proapoptotic potential of <em>B. lupulina</em> leaf extract with understanding of cellular and molecular mechanisms.</div></div><div><h3>Materials and methods</h3><div>The ethanolic extract was characterized using liquid chromatography-mass spectrometry and its anticancer activity was then assessed against Caco-2 colon cancer and A549 lung cancer cell lines.</div></div><div><h3>Results</h3><div>Phytochemical analysis of the extract revealed the presence of acetylbarlerin, decaffeoylacteoside, gallic acid, ipolamiide, leonuriside A, shanzhiside, and vanillic acid. The extract showed concentration-dependent cytotoxicity against both cancer cells. It induced early apoptosis at lower concentrations and late apoptosis at higher concentrations. Moreover, the extract noticeably reduced reactive oxygen species and mitochondrial membrane potential in a concentration-dependent way. The Western blot and quantitative reverse transcription polymerase chain reaction showed upregulation of Bax, caspase-8, caspase-9, and cluster of differentiation 95, and downregulation of Bcl-2. Molecular docking studies revealed that decaffeoylacteoside, gallic acid, and vanillic acid exhibited dual affinities for both caspase-8 and caspase-9, while acetylbarlerin, ipolamiide, leonuriside A, and shanzhiside showed selective affinities only for caspase-9.</div></div><div><h3>Conclusion</h3><div>The ethanolic leaf extract shows significant cytotoxic and proapoptotic activities, confirming its potential as a useful resource of bioactive compounds against cancer. Nevertheless, more in-depth investigations are necessary to realize the full potential of this medicinal plant for cancer therapy.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101220"},"PeriodicalIF":1.9,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IFTAK technique for management of anterior fistulae in ano in female patients - A case series IFTAK技术在治疗女性患者肛门前瘘中的应用-一个病例系列
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-25 DOI: 10.1016/j.jaim.2025.101170
K.T. Aadithyaraj, Rahul Sherkhane, Awadhesh Kumar Pandey, Sarika Solanki, Shivani Katkar
Anterior fistula in ano is an uncommon and challenging condition in females, with sparse literature describing effective management strategies. Surgical interventions are often complicated by the anatomical intricacies of the pelvic region. This case series explores the use of the Interception of Fistulous Tract with the Application of Ksharasutra (IFTAK) technique, a modification of traditional Ksharasutra therapy, in managing anterior fistulae in ano among female patients. Three female patients with anterior anal fistulae, two with failed prior surgical interventions, were included. Comprehensive preoperative evaluations, including clinical and radiological assessments, were performed. The IFTAK technique was employed, emphasizing tract interception and eradication of sepsis without compromising the anal sphincter. All patients achieved complete healing within 8 weeks post-procedure. No recurrence, incontinence, or significant complications were observed during a 12-month follow-up. The IFTAK technique is a promising approach for anterior fistulae in ano in females, offering high success rates with minimal complications. While the results are encouraging, validation through well-designed randomized controlled trials is essential for its broader adoption as a standard treatment for complex anal fistulas.
肛门前瘘在女性中是一种罕见且具有挑战性的疾病,文献很少描述有效的管理策略。手术干预往往是复杂的解剖盆腔区域。本病例系列探讨了在女性患者中应用Ksharasutra (IFTAK)技术(一种对传统Ksharasutra疗法的改进)阻断瘘道治疗前瘘的应用。本研究包括三名女性前肛瘘患者,其中两名先前手术干预失败。进行全面的术前评估,包括临床和放射学评估。采用IFTAK技术,强调在不损害肛门括约肌的情况下阻断和根除脓毒症。所有患者均在术后8周内完全愈合。随访12个月,无复发、尿失禁或显著并发症。IFTAK技术是治疗女性肛门前瘘的一种很有前途的方法,成功率高,并发症少。虽然结果令人鼓舞,但通过精心设计的随机对照试验进行验证对于将其广泛采用为复杂肛瘘的标准治疗至关重要。
{"title":"IFTAK technique for management of anterior fistulae in ano in female patients - A case series","authors":"K.T. Aadithyaraj,&nbsp;Rahul Sherkhane,&nbsp;Awadhesh Kumar Pandey,&nbsp;Sarika Solanki,&nbsp;Shivani Katkar","doi":"10.1016/j.jaim.2025.101170","DOIUrl":"10.1016/j.jaim.2025.101170","url":null,"abstract":"<div><div>Anterior fistula in ano is an uncommon and challenging condition in females, with sparse literature describing effective management strategies. Surgical interventions are often complicated by the anatomical intricacies of the pelvic region. This case series explores the use of the Interception of Fistulous Tract with the Application of Ksharasutra (IFTAK) technique, a modification of traditional Ksharasutra therapy, in managing anterior fistulae in ano among female patients. Three female patients with anterior anal fistulae, two with failed prior surgical interventions, were included. Comprehensive preoperative evaluations, including clinical and radiological assessments, were performed. The IFTAK technique was employed, emphasizing tract interception and eradication of sepsis without compromising the anal sphincter. All patients achieved complete healing within 8 weeks post-procedure. No recurrence, incontinence, or significant complications were observed during a 12-month follow-up. The IFTAK technique is a promising approach for anterior fistulae in ano in females, offering high success rates with minimal complications. While the results are encouraging, validation through well-designed randomized controlled trials is essential for its broader adoption as a standard treatment for complex anal fistulas.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101170"},"PeriodicalIF":1.7,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144703292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Swarna Bhasma reduces the blood concentration of tumor-specific signatures and protects from hepatocellular damages in Ehrlich ascites mice model 在埃利希腹水小鼠模型中,Swarna Bhasma降低肿瘤特异性信号的血液浓度并保护肝细胞免受损伤
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-24 DOI: 10.1016/j.jaim.2025.101152
Namrata Joshi , Pankaj Kumar , Shiwakshi Sharma , Remya Jayakumar , Anand Mishra , V. Harsha , Manoj Kumar Dash

Background

The paradigm shift with alarmingly high rate of global cancer incidences encourages the application of incinerated gold Nano powder, Swarna Bhasma (SB) due to its exceptional potency, affordability, and minimal toxic effects. Previous experimental investigations were unable to provide a biochemical understanding of the anti-carcinogenic properties of SB.

Objective

To evaluate the tumour related markers in blood and possible alteration in hepatic parameters due to SB.

Methods

EAC (Ehrlich’s Ascites Carcinoma) induced tumour was generated in the female Swiss albino mice divided into 6 groups, namely, Vehicle Control (VC), Disease Control (DC), Standard Control (SC), and Treatment Groups with escalating doses (1.95, 3.9, and 7.8 mg/kg body weight) of SB. Blood serum quantified was measured for the levels of CEA (Carcinoembryonic antigen), TNF-α (Tumour Necrosis Factoralpha), IL-6 (Interleukin-6), ALT (Alanine transaminase), and AST (Aspartate aminotransferase). Changes in daily food consumption, body weight, and tumour volume (with Vernier caliper) were coherently studied and analysed. The data was analysed using One-Way ANOVA and Tukey's Honest Significance Test.

Result

SB demonstrated effective reduction of CEA levels at higher doses, and TNF-α levels at medium doses. Both moderate and high doses exhibited a noteworthy, dosedependent decrease in IL-6 levels. Furthermore, SB led to a dose-dependent reduction in the AST/ALT ratio. A significant reduction in tumour volume were reported in both the moderate and high doses of SB along with marked improvement in anorexia. The higher doses of SB exhibited the serum validated results in the hepatic, renal and the splenic tissues.

Conclusion

The anti-carcinogenic activity of SB appeared to be dose-dependent. The finding also underscored the hepato-protective capability of SB in lower dose by alleviating cancer-related liver damage
全球癌症发病率高得惊人,这种范式转变鼓励了焚烧金纳米粉末的应用,因为它具有非凡的效力、可负担性和最小的毒性作用。目的探讨sbc对小鼠血液中肿瘤相关标志物的影响及sbc对肝脏参数的影响。方法将雌性瑞士白化小鼠seac (Ehrlich’s as腹水癌)诱导的肿瘤分为6组,分别为载体对照组(VC)、疾病对照组(DC)、标准对照组(SC)和剂量递增治疗组(1.95,3.9,测定血清CEA(癌胚抗原)、TNF-α(肿瘤坏死因子α)、IL-6(白细胞介素-6)、ALT(谷丙转氨酶)、AST(天冬氨酸转氨酶)水平。对每日食物摄入量、体重和肿瘤体积(用游标卡尺)的变化进行了连贯的研究和分析。数据分析采用单因素方差分析和Tukey's Honest显著性检验。结果高剂量b能有效降低CEA水平,中剂量b能有效降低TNF-α水平。中等剂量和高剂量均表现出明显的剂量依赖性IL-6水平下降。此外,SB导致AST/ALT比率呈剂量依赖性降低。据报道,在中等和高剂量的SB中,肿瘤体积显著减少,厌食症明显改善。高剂量SB在肝、肾和脾组织中显示出血清验证的结果。结论SB的抗癌作用呈剂量依赖性。该发现还强调了低剂量SB通过减轻癌症相关肝损伤而具有肝保护能力
{"title":"Swarna Bhasma reduces the blood concentration of tumor-specific signatures and protects from hepatocellular damages in Ehrlich ascites mice model","authors":"Namrata Joshi ,&nbsp;Pankaj Kumar ,&nbsp;Shiwakshi Sharma ,&nbsp;Remya Jayakumar ,&nbsp;Anand Mishra ,&nbsp;V. Harsha ,&nbsp;Manoj Kumar Dash","doi":"10.1016/j.jaim.2025.101152","DOIUrl":"10.1016/j.jaim.2025.101152","url":null,"abstract":"<div><h3><strong>Background</strong></h3><div>The paradigm shift with alarmingly high rate of global cancer incidences encourages the application of incinerated gold Nano powder, Swarna Bhasma (SB) due to its exceptional potency, affordability, and minimal toxic effects. Previous experimental investigations were unable to provide a biochemical understanding of the anti-carcinogenic properties of SB.</div></div><div><h3><strong>Objective</strong></h3><div>To evaluate the tumour related markers in blood and possible alteration in hepatic parameters due to SB.</div></div><div><h3><strong>Methods</strong></h3><div>EAC (Ehrlich’s Ascites Carcinoma) induced tumour was generated in the female Swiss albino mice divided into 6 groups, namely, Vehicle Control (VC), Disease Control (DC), Standard Control (SC), and Treatment Groups with escalating doses (1.95, 3.9, and 7.8 mg/kg body weight) of SB. Blood serum quantified was measured for the levels of CEA (Carcinoembryonic antigen), TNF-α (Tumour Necrosis Factoralpha), IL-6 (Interleukin-6), ALT (Alanine transaminase), and AST (Aspartate aminotransferase). Changes in daily food consumption, body weight, and tumour volume (with Vernier caliper) were coherently studied and analysed. The data was analysed using One-Way ANOVA and Tukey's Honest Significance Test.</div></div><div><h3><strong>Result</strong></h3><div>SB demonstrated effective reduction of CEA levels at higher doses, and TNF-α levels at medium doses. Both moderate and high doses exhibited a noteworthy, dosedependent decrease in IL-6 levels. Furthermore, SB led to a dose-dependent reduction in the AST/ALT ratio. A significant reduction in tumour volume were reported in both the moderate and high doses of SB along with marked improvement in anorexia. The higher doses of SB exhibited the serum validated results in the hepatic, renal and the splenic tissues.</div></div><div><h3><strong>Conclusion</strong></h3><div>The anti-carcinogenic activity of SB appeared to be dose-dependent. The finding also underscored the hepato-protective capability of SB in lower dose by alleviating cancer-related liver damage</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101152"},"PeriodicalIF":1.7,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144695020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Ayurvedic intervention for pseudomyxoma peritonei - A case report 阿育吠陀治疗腹膜假性黏液瘤1例
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-23 DOI: 10.1016/j.jaim.2025.101166
Divya Sukumar, T. Sreekumar, P.V. Smitha Mohan, K. Shaji, A. Athulya
Cancer is the deadliest disease in the world and cancer treatment remains as a challenge among all systems of medicine. Pseudomyxoma peritonei is one of the rarest malignancies, devoid of any promising management strategies. Ayurvedic perspective of diagnosis and reports on treatment strategies for such malignant conditions are highly limited. In this study, a male patient with pseudomyxoma peritonei, presented with breathlessness, abdominal distension, inguinal hernia and swelling of both legs with oozing. CT and biopsy reports diagnosed the disease as Pseudomyxoma Peritonei. He was provided with ayurvedic treatment for improving Quality of Life. Paniya kshara and Bhallathaka vati were the principal contents of the medication given. Other medications are Punarnavadi kashaya, chirivilwadi kashaya, Tab Neem, Tab Haridra, Cap Rasasindoor and Cap Poornachandrodaya rasa. After 90 days of treatment, patient got relief from breathlessness, leg swelling and oozing. The abdominal circumference also reduced remarkably from 108cm to 78cm, and the Quality of Life also improved. The treatment principle adopted was based on the concepts of udara, arbuda and sopha. Cautious combination of concepts from Ayurveda can provide effective treatment strategies to treat rare diseases.
癌症是世界上最致命的疾病,癌症治疗仍然是所有医学系统面临的挑战。腹膜假性黏液瘤是一种罕见的恶性肿瘤,缺乏任何有希望的治疗策略。阿育吠陀的诊断观点和报道的治疗策略对这种恶性条件是非常有限的。在本研究中,一位患有腹膜假性黏液瘤的男性患者,表现为呼吸困难,腹胀,腹股沟疝和双腿肿胀并渗出。CT和活检报告诊断为腹膜假性粘液瘤。他接受了阿育吠陀治疗,以提高生活质量。Paniya kshara和Bhallathaka vati是所给药物的主要内容。其他药物有Punarnavadi kashaya, chirivilwadi kashaya, Tab Neem, Tab Haridra, Cap Rasasindoor和Cap Poornachandrodaya rasa。经过90天的治疗,患者呼吸困难,腿部肿胀和渗血症状得到缓解。腹围也从108厘米明显减少到78厘米,生活质量也有所提高。所采用的治疗原则是基于udara, arbuda和sopha的概念。谨慎结合阿育吠陀的概念,可以为治疗罕见疾病提供有效的治疗策略。
{"title":"An Ayurvedic intervention for pseudomyxoma peritonei - A case report","authors":"Divya Sukumar,&nbsp;T. Sreekumar,&nbsp;P.V. Smitha Mohan,&nbsp;K. Shaji,&nbsp;A. Athulya","doi":"10.1016/j.jaim.2025.101166","DOIUrl":"10.1016/j.jaim.2025.101166","url":null,"abstract":"<div><div>Cancer is the deadliest disease in the world and cancer treatment remains as a challenge among all systems of medicine. Pseudomyxoma peritonei is one of the rarest malignancies, devoid of any promising management strategies. Ayurvedic perspective of diagnosis and reports on treatment strategies for such malignant conditions are highly limited. In this study, a male patient with pseudomyxoma peritonei, presented with breathlessness, abdominal distension, inguinal hernia and swelling of both legs with oozing. CT and biopsy reports diagnosed the disease as Pseudomyxoma Peritonei. He was provided with ayurvedic treatment for improving Quality of Life. <em>Paniya kshara</em> and <em>Bhallathaka vati</em> were the principal contents of the medication given. Other medications are <em>Punarnavadi kashaya, chirivilwadi kashaya</em>, Tab Neem, Tab <em>Haridra,</em> Cap <em>Rasasindoor</em> and Cap <em>Poornachandrodaya ras</em><em>a</em><em>.</em> After 90 days of treatment, patient got relief from breathlessness, leg swelling and oozing. The abdominal circumference also reduced remarkably from 108cm to 78cm, and the Quality of Life also improved. The treatment principle adopted was based on the concepts of <em>udara, arbuda</em> and <em>sopha</em>. Cautious combination of concepts from Ayurveda can provide effective treatment strategies to treat rare diseases.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101166"},"PeriodicalIF":1.7,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144686404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Panchakarma treatment for painful Post-Traumatic Trigeminal Neuropathy – A case report Panchakarma治疗疼痛性创伤后三叉神经病变1例
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101168
Manoj Shamkuwar , Kiran Nimbalkar , Diwakar Mani Tripathi , Bhavna Bhatia , Manisha , Rohit Pal
Trigeminal Neuralgia (TN) is characterized by sudden, electric shock-like pain triggered by innocuous stimuli. Post-Traumatic Trigeminal Neuropathy (PTTN), a traumatic subset of TN, shares these features but also involves sensory abnormalities and psychological distress. Conventional treatments, including medications and surgical interventions, often provide limited relief and have their limitations. Ayurveda offers a more holistic, non-invasive alternative for long-term management. This case study details a 45-year-old male patient with right-sided facial pain persisting for eight months, unresponsive to conventional medications. Baseline pain intensity was six out of ten on the Numerical Rating Scale (NRS). The interventions comprised Virechana (therapeutic purgation), Ksheera-bashpa Swedana (therapeutic steam of medicated milk), Nasya (medication through nasal route), Shirodhara (therapeutic streaming over head), and Matra Basti (a form of unctuous enema), followed by a seven-month course of medications. During the course of treatment, pain intensity gradually reduced from six to one on the NRS, accompanied by significant improvements in emotional well-being, sleep, and overall quality of life. Follow-up assessments confirmed sustained benefits, including a decreased dependence on conventional medication. This case highlights the potential of Ayurveda in PTTN management. More case reports and series of this kind are desirable for a better insight into this management approach.
三叉神经痛(TN)的特征是由无害刺激引起的突然的电击样疼痛。创伤后三叉神经病变(PTTN)是创伤性三叉神经病变的一个子集,具有这些特征,但也涉及感觉异常和心理困扰。传统的治疗方法,包括药物治疗和外科手术,往往提供有限的缓解,并有其局限性。阿育吠陀为长期治疗提供了更全面、非侵入性的选择。本病例研究详细介绍了一位45岁男性患者,右侧面部疼痛持续8个月,对常规药物无反应。基线疼痛强度在数值评定量表(NRS)上为6分(满分为10分)。干预措施包括Virechana(治疗性净化)、Ksheera-bashpa Swedana(治疗性药奶蒸汽)、Nasya(通过鼻腔给药)、Shirodhara(治疗性头部流)和Matra Basti(一种润滑灌肠),随后是7个月的疗程。在治疗过程中,疼痛强度从NRS的6分逐渐降低到1分,伴随着情绪健康、睡眠和整体生活质量的显著改善。随访评估证实了持续的益处,包括减少对传统药物的依赖。这个案例突出了阿育吠陀在PTTN管理中的潜力。为了更好地了解这种管理方法,需要更多的案例报告和此类系列。
{"title":"Panchakarma treatment for painful Post-Traumatic Trigeminal Neuropathy – A case report","authors":"Manoj Shamkuwar ,&nbsp;Kiran Nimbalkar ,&nbsp;Diwakar Mani Tripathi ,&nbsp;Bhavna Bhatia ,&nbsp;Manisha ,&nbsp;Rohit Pal","doi":"10.1016/j.jaim.2025.101168","DOIUrl":"10.1016/j.jaim.2025.101168","url":null,"abstract":"<div><div>Trigeminal Neuralgia (TN) is characterized by sudden, electric shock-like pain triggered by innocuous stimuli. Post-Traumatic Trigeminal Neuropathy (PTTN), a traumatic subset of TN, shares these features but also involves sensory abnormalities and psychological distress. Conventional treatments, including medications and surgical interventions, often provide limited relief and have their limitations. <em>Ayurveda</em> offers a more holistic, non-invasive alternative for long-term management. This case study details a 45-year-old male patient with right-sided facial pain persisting for eight months, unresponsive to conventional medications. Baseline pain intensity was six out of ten on the Numerical Rating Scale (NRS). The interventions comprised <em>Virechana</em> (therapeutic purgation)<em>, Ksheera-bashpa Swedana</em> (therapeutic steam of medicated milk), <em>Nasya</em> (medication through nasal route)<em>, Shirodhara</em> (therapeutic streaming over head)<em>,</em> and <em>Matra Basti</em> (a form of unctuous enema), followed by a seven-month course of medications. During the course of treatment, pain intensity gradually reduced from six to one on the NRS, accompanied by significant improvements in emotional well-being, sleep, and overall quality of life. Follow-up assessments confirmed sustained benefits, including a decreased dependence on conventional medication. This case highlights the potential of <em>Ayurveda</em> in PTTN management. More case reports and series of this kind are desirable for a better insight into this management approach.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101168"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144548589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research on Yoga for stress management: Bibliometric trends from 2000 to 2024 瑜伽对压力管理的研究:2000年至2024年的文献计量趋势
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101163
Juhi Kumawat, Kashinath G. Metri

Background

Yoga has emerged as a widely recognized intervention for managing stress, with growing interest in its effectiveness across various populations. Despite expanding research, there remains a need for comprehensive analysis of trends within the literature to guide future studies and clinical applications.

Objective

This study aimed to analyze bibliometric trends in research on yoga for stress management, providing insights into publication patterns, key contributors, and evolving research directions in this field.

Methods

The experimental studies related application of yoga for stress management were searched from 2000 to 2024 on Scopus database. The search criteria were refined to include publications on yoga related to stress, with a focus exclusively on articles published in English. Quantitative data analysis was conducted using bibliometric tools, with visualizations created using VOSviewer.

Results

The analysis of 1025 articles revealed a significant increase in publications over 24 years, especially in the past four years. The International Journal of Yoga Therapy and the Journal of Alternative and Complementary Medicine were leading journals in this field. The United States and India were identified as primary contributors, with Khalsa SBS and Nagendra HR being the most prolific authors. Randomized controlled trials, meta-analyses, and systematic reviews emerged as predominant study types.

Conclusion

This comprehensive bibliometric analysis highlights the growth of yoga and stress management research, emphasizing randomized controlled trials and evidence-based practices. Future studies should explore yoga’s impact on diverse populations by age, occupation, and culture to clarify its universal applicability, advancing research and clinical applications.
瑜伽已经成为一种被广泛认可的管理压力的干预手段,人们对它在不同人群中的有效性越来越感兴趣。尽管研究不断扩大,但仍需要对文献中的趋势进行全面分析,以指导未来的研究和临床应用。目的分析瑜伽对压力管理研究的文献计量学趋势,了解该领域的出版模式、主要贡献者和发展方向。方法检索Scopus数据库2000 ~ 2024年有关瑜伽在压力管理中的应用的实验研究。我们对搜索标准进行了改进,纳入了与压力相关的瑜伽出版物,并且只关注用英语发表的文章。使用文献计量学工具进行定量数据分析,并使用VOSviewer创建可视化。结果对1025篇文献的分析显示,近24年,特别是近4年的文献发表量明显增加。《国际瑜伽疗法杂志》和《替代和补充医学杂志》是这一领域的主要期刊。美国和印度被确定为主要贡献者,其中Khalsa SBS和Nagendra HR是最多产的作者。随机对照试验、荟萃分析和系统评价成为主要的研究类型。这项全面的文献计量分析强调了瑜伽和压力管理研究的增长,强调了随机对照试验和循证实践。未来的研究应该探索瑜伽对不同年龄、职业和文化人群的影响,以阐明其普遍适用性,推进研究和临床应用。
{"title":"Research on Yoga for stress management: Bibliometric trends from 2000 to 2024","authors":"Juhi Kumawat,&nbsp;Kashinath G. Metri","doi":"10.1016/j.jaim.2025.101163","DOIUrl":"10.1016/j.jaim.2025.101163","url":null,"abstract":"<div><h3>Background</h3><div>Yoga has emerged as a widely recognized intervention for managing stress, with growing interest in its effectiveness across various populations. Despite expanding research, there remains a need for comprehensive analysis of trends within the literature to guide future studies and clinical applications.</div></div><div><h3>Objective</h3><div>This study aimed to analyze bibliometric trends in research on yoga for stress management, providing insights into publication patterns, key contributors, and evolving research directions in this field.</div></div><div><h3>Methods</h3><div>The experimental studies related application of yoga for stress management were searched from 2000 to 2024 on Scopus database. The search criteria were refined to include publications on yoga related to stress, with a focus exclusively on articles published in English. Quantitative data analysis was conducted using bibliometric tools, with visualizations created using VOSviewer.</div></div><div><h3>Results</h3><div>The analysis of 1025 articles revealed a significant increase in publications over 24 years, especially in the past four years. The International Journal of Yoga Therapy and the Journal of Alternative and Complementary Medicine were leading journals in this field. The United States and India were identified as primary contributors, with Khalsa SBS and Nagendra HR being the most prolific authors. Randomized controlled trials, meta-analyses, and systematic reviews emerged as predominant study types.</div></div><div><h3>Conclusion</h3><div>This comprehensive bibliometric analysis highlights the growth of yoga and stress management research, emphasizing randomized controlled trials and evidence-based practices. Future studies should explore yoga’s impact on diverse populations by age, occupation, and culture to clarify its universal applicability, advancing research and clinical applications.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101163"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144572112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse systemic sclerosis managed with ayurvedic treatment modalities – A case report 用阿育吠陀疗法治疗弥漫性系统性硬化症--病例报告。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2023.100883
Ranjani Karthik Pandit
Diffuse systemic sclerosis or scleroderma is a chronic connective tissue disorder involving many systems and visceral organs. The association of interstitial lung disease carries high mortality risk. This is a case report of a patient aged 25-years, who was diagnosed as diffuse systemic sclerosis, a disease complex along with Interstitial Lung Disease (ILD), sclerodactyly. She also presented with digital ulcers and calcium deposits in the ulcers. The symptomatology was understood by analysing the dosha predominance and the composition of the different qualities of each dosha in the patient. This complicated case with a bad prognosis was managed with Ayurvedic treatment procedures and medicines. Matrabasti (medicated enema) with maha masha taila and dhanvantara taila was given. yogabasti with dashamoola ksheera paka, dhanvantara taila and madhu (decoctive enema), along with other palliative medicines like rasna yoga raja, Yogendra rasa, vasakasava, drakshadi paka, kaishora guggulu, raktapachaka ghana vati and Mahatiktaka ghrita were given to the patient. After 1-1.2 years of continuous treatments, patient started showing gradual changes in her health condition. Relief from joint pains, intake of normal food, weight gain, re-establishment of menstruation, healing of ulcers was some of the changes seen in the patient. This case report summaries the effective management of diffuse systemic sclerosis after deducing the complex disease structure to dosa and guna involved and treated by adopting ayurvedic medicine and treatment procedures.
弥漫性系统性硬化症或硬皮病是一种慢性结缔组织疾病,涉及多个系统和内脏器官。与间质性肺部疾病相关的死亡率很高。这是一份 25 岁患者的病例报告,她被诊断为弥漫性系统性硬化症,这是一种与间质性肺病(ILD)和硬皮病并存的复合疾病。她还出现了数字溃疡和溃疡中的钙沉积。通过分析患者体内的 "道"(dosha)占主导地位以及每种 "道"(dosha)不同性质的组成,我们了解了患者的症状。对这一预后不良的复杂病例采用了阿育吠陀治疗程序和药物进行治疗。患者接受了含有 mahamasha taila 和 dhanvantara taila 的 Matrabasti(药物灌肠),含有 dashamoola ksheera paka、dhanvantara taila 和 madhu(煎药灌肠)的 yogabasti,以及其他缓和药物,如 rasna yoga raja、Yogendra rasa、vasakasava、drakshadi paka、kaishora guggulu、raktapachakaghana vati 和 Mahatiktaka ghrita。经过 1-1.2 年的持续治疗,患者的健康状况开始逐渐发生变化。患者的关节疼痛缓解,可以进食正常食物,体重增加,月经恢复,溃疡愈合,这些都是患者身上出现的一些变化。本病例报告总结了弥漫性系统性硬化症的有效治疗方法,通过对复杂的疾病结构进行推断,得出了涉及多沙和古纳的病因,并采用阿育吠陀医学和治疗程序进行治疗。
{"title":"Diffuse systemic sclerosis managed with ayurvedic treatment modalities – A case report","authors":"Ranjani Karthik Pandit","doi":"10.1016/j.jaim.2023.100883","DOIUrl":"10.1016/j.jaim.2023.100883","url":null,"abstract":"<div><div>Diffuse systemic sclerosis or scleroderma is a chronic connective tissue disorder involving many systems and visceral organs. The association of interstitial lung disease carries high mortality risk. This is a case report of a patient aged 25-years, who was diagnosed as diffuse systemic sclerosis, a disease complex along with Interstitial Lung Disease (ILD), sclerodactyly. She also presented with digital ulcers and calcium deposits in the ulcers. The symptomatology was understood by analysing the <em>dosha</em> predominance and the composition of the different qualities of each dosha in the patient. This complicated case with a bad prognosis was managed with Ayurvedic treatment procedures and medicines. <em>Matrabasti</em> (medicated enema) with <em>maha</em> <em>masha taila</em> and <em>dhanvantara taila</em> was given. yogabasti with <em>dashamoola ksheera paka</em>, <em>dhanvantara taila</em> and <em>madhu</em> (decoctive enema), along with other palliative medicines like <em>rasna yoga raja</em>, <em>Yogendra rasa</em>, <em>vasakasava, drakshadi paka</em>, <em>kaishora guggulu</em>, <em>raktapachaka</em> <em>ghana vati</em> and <em>Mahatiktaka ghrita</em> were given to the patient. After 1-1.2 years of continuous treatments, patient started showing gradual changes in her health condition. Relief from joint pains, intake of normal food, weight gain, re-establishment of menstruation, healing of ulcers was some of the changes seen in the patient. This case report summaries the effective management of diffuse systemic sclerosis after deducing the complex disease structure to dosa and guna involved and treated by adopting ayurvedic medicine and treatment procedures.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 100883"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140957567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative efficacy of Medhya Rasayana, Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8–10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial 中草药、假马齿苋和积雪草增强8-10岁健康男孩记忆力和智商的比较疗效:一项基于prakriti的双盲、随机对照试验
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101164
Jitesh Verma , Renu Rathi , Anamika , Bharat Rathi , Vidya Bhushan Pandey

Background

Cognitive problems like learning difficulties, memory problems, intellectual disability, and ADHD are highly associated with school absenteeism and high dropout rates. The novel approach to improving memory and learning in these children is using nootropic herbs known as Medhya Rasayana (intellect enhancer) in Ayurveda. Brahmi (Bacopa monnieri L. Pannel), one of the Medhya Rasayana, has proven to be useful through extensive research. Still, the other Medhya Rasayana requires thorough research based on the Ayurvedic principle of Prakriti (constitution) to utilize their optimum therapeutic effect.

Objectives

The main objective of this study was to evaluate the comparative efficacy of Mandookaparni in enhancing the memory of healthy boys with dominant Prakriti.

Material & methods

The present study was a double-blind, randomized study to evaluate the comparative efficacy of Brahmi (Bacopa monnieri L. Pannel) and Mandookaparni (Centella asiatica L. Urban) in enhancing the memory of 8-10-year-old healthy boys with dominant Prakriti. After obtaining informed consent from parents and assent from the participants, the eligible study participants were randomized to either the Mandookaparni or the Brahmi group. The participants were assessed at baseline and end of the treatment (91st day) for efficacy measures, which included total memory score and various domains of memory assessed by the Post Graduate Institute- Children's Memory Scale (PGI-CMS) and Intelligence Quotient.

Results

On analysis of 180 participants, the Brahmi group showed highly significant results in the total memory score, 9 out of 10 subsets of PGI-CMS, and IQ with p < 0.001. The Mandookaparni group showed highly significant results in 8 subsets of PGI-CMS, the total memory score, and IQ with p < 0.001. Brahmi increased the mean total memory score by 9.28 %, while a 13.45 % rise was observed with Mandookaparni. Significant differences were observed chiefly in Pitta Prakriti on Prakriti-wise analysis in the improvement of various memory domains between Brahmi and Mandookaparni.

Conclusions

Mandookaparni has clinically equivalent efficacy to Brahmi in enhancing memory. Mandookaparni is better in improving the memory of Pitta Prakriti people while Brahmi is more effective in Kapha and Vata Prakriti. Both drugs are safe and effective in the pediatric population.
学习困难、记忆问题、智力残疾和多动症等认知问题与学校缺勤和高辍学率密切相关。提高这些孩子的记忆力和学习能力的新方法是使用阿育吠陀中被称为“智力增强剂”的益智草药。婆罗门(Bacopa monnieri L. Pannel),其中一个Medhya Rasayana,已被证明是有用的,通过广泛的研究。尽管如此,其他的Medhya Rasayana需要基于阿育吠陀的Prakriti(体质)原则进行彻底的研究,以利用其最佳的治疗效果。目的本研究的主要目的是评价Mandookaparni在增强Prakriti显性健康男孩记忆方面的比较疗效。材料,方法采用双盲、随机对照研究,比较假马齿苋(Bacopa monnieri L. Pannel)和Mandookaparni (Centella asiatica L. Urban)对8-10岁Prakriti显性男孩记忆力的改善效果。在获得父母和参与者的知情同意后,符合条件的研究参与者被随机分为Mandookaparni组和Brahmi组。在基线和治疗结束时(第91天)对参与者进行疗效评估,包括总记忆评分和由研究生院-儿童记忆量表(PGI-CMS)和智商评估的各种记忆领域。结果在对180名参与者的分析中,Brahmi组在总记忆得分、PGI-CMS的10个子集中的9个以及IQ (p <;0.001. Mandookaparni组在PGI-CMS的8个亚组、总记忆评分和IQ (p <;0.001. Brahmi组的平均总记忆评分提高了9.28%,而Mandookaparni组的平均总记忆评分提高了13.45%。在Prakriti-wise分析中,在Brahmi和Mandookaparni之间的各种记忆领域的改善方面,主要观察到Pitta Prakriti的显著差异。结论曼度卡帕尼与布罗米在增强记忆方面具有相当的临床疗效。Mandookaparni在改善Pitta Prakriti人的记忆方面更好,而Brahmi在Kapha和Vata Prakriti方面更有效。这两种药物对儿科人群都是安全有效的。
{"title":"Comparative efficacy of Medhya Rasayana, Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8–10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial","authors":"Jitesh Verma ,&nbsp;Renu Rathi ,&nbsp;Anamika ,&nbsp;Bharat Rathi ,&nbsp;Vidya Bhushan Pandey","doi":"10.1016/j.jaim.2025.101164","DOIUrl":"10.1016/j.jaim.2025.101164","url":null,"abstract":"<div><h3>Background</h3><div>Cognitive problems like learning difficulties, memory problems, intellectual disability, and ADHD are highly associated with school absenteeism and high dropout rates. The novel approach to improving memory and learning in these children is using nootropic herbs known as <em>Medhya Rasayana</em> (intellect enhancer) in Ayurveda. <em>Brahmi</em> (<em>Bacopa monnieri</em> L. Pannel), one of the Medhya Rasayana, has proven to be useful through extensive research. Still, the other <em>Medhya Rasayana</em> requires thorough research based on the Ayurvedic principle of <em>Prakriti</em> (constitution) to utilize their optimum therapeutic effect.</div></div><div><h3>Objectives</h3><div>The main objective of this study was to evaluate the comparative efficacy of <em>Mandookaparni</em> in enhancing the memory of healthy boys with dominant <em>Prakriti</em>.</div></div><div><h3>Material &amp; methods</h3><div>The present study was a double-blind, randomized study to evaluate the comparative efficacy of <em>Brahmi</em> (<em>Bacopa monnieri</em> L. Pannel) and <em>Mandookaparni</em> (<em>Centella asiatica</em> L. Urban) in enhancing the memory of 8-10-year-old healthy boys with dominant <em>Prakriti</em>. After obtaining informed consent from parents and assent from the participants, the eligible study participants were randomized to either the <em>Mandookaparni</em> or the <em>Brahmi</em> group. The participants were assessed at baseline and end of the treatment (91st day) for efficacy measures, which included total memory score and various domains of memory assessed by the Post Graduate Institute- Children's Memory Scale (PGI-CMS) and Intelligence Quotient.</div></div><div><h3>Results</h3><div>On analysis of 180 participants, the <em>Brahmi</em> group showed highly significant results in the total memory score, 9 out of 10 subsets of PGI-CMS, and IQ with p &lt; 0.001. The <em>Mandookaparni</em> group showed highly significant results in 8 subsets of PGI-CMS, the total memory score, and IQ with p &lt; 0.001. <em>Brahmi</em> increased the mean total memory score by 9.28 %, while a 13.45 % rise was observed with <em>Mandookaparni</em>. Significant differences were observed chiefly in <em>Pitta Prakriti</em> on Prakriti-wise analysis in the improvement of various memory domains between <em>Brahmi</em> and <em>Mandookaparni</em>.</div></div><div><h3>Conclusions</h3><div><em>Mandookaparni</em> has clinically equivalent efficacy to <em>Brahmi</em> in enhancing memory. <em>Mandookaparni</em> is better in improving the memory of <em>Pitta Prakriti</em> people while <em>Brahmi</em> is more effective in <em>Kapha</em> and <em>Vata Prakriti</em>. Both drugs are safe and effective in the pediatric population.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101164"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144534651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beneficial effect of cow urine on stem cell differentiation, senescence, oxidative stress and angiogenesis in chick yolk sac model 牛尿对鸡卵黄囊干细胞分化、衰老、氧化应激和血管生成的有益影响
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101194
Avinash Kharat, Swapnali Sakhare, Avinash Sanap, Pranjali Potdar, Supriya Kheur, Ramesh Bhonde

Background

Cow urine has been utilized in traditional Indian medicine for the treatment of various ailments such as wounds, oxidative stress, and the management of various metabolic disorders with limited toxicity. However, there is a scarcity of scientific evidence confirming its exact mode of action.

Objectives

The aim of the study is to examine the mode of action of cow urine, also known as "Gomutra", focusing on its effect on human dental pulp stem cells (DPSCs) and chick yolk sac membrane (YSM) models.

Material and methods

DPSCs were isolated and characterised using a flow analyser, and used to assess the cytotoxicity, osteogenic and chondrogenic differentiation potential, anti-aging activity, anti-oxidative nature. Angiogenic potential was evaluated by YSM model.

Results

DPSCs showed fibroblast-like morphology and expressed mesenhymal stem cell markers viz., CD73, CD90, and CD105, and lacked expression of CD34, CD45 and HLA-DR. Our findings indicated that cow urine showed no toxicity at 1, 2, 4, 5, 10, 20 and 25% concentrations and promoted osteogenic and chondrogenic differentiation of DPSCs compared to standard controls. Additionally, cow urine effectively reduced oxidative stress and delayed cellular senescence in DPSCs, suggesting its anti-aging potential. Further, the study evidenced cow urine's angiogenic activity through YSM model.

Conclusion

This study provides substantial evidence for the non-toxic nature of cow urine. Our data demonstrates bone and cartilage regeneration, ant-aging, angiogenic and anti-oxidative nature of cow urine indicating its therapeutic value.
背景:牛尿在传统印度医学中被用于治疗各种疾病,如伤口、氧化应激和各种毒性有限的代谢紊乱。然而,缺乏科学证据证实其确切的作用方式。目的探讨牛尿(Gomutra)对人牙髓干细胞(DPSCs)和鸡卵黄囊膜(YSM)模型的作用机制。材料和方法分离sdpsc并使用流动分析仪进行表征,并用于评估细胞毒性,成骨和软骨分化潜力,抗衰老活性,抗氧化性质。采用YSM模型评价血管生成潜能。结果dpscs呈成纤维细胞样形态,表达间充质干细胞标志物CD73、CD90和CD105,缺乏CD34、CD45和HLA-DR的表达。我们的研究结果表明,与标准对照相比,牛尿在1、2、4、5、10、20和25%浓度下没有毒性,并且促进了DPSCs的成骨和软骨分化。此外,牛尿可有效降低DPSCs的氧化应激,延缓细胞衰老,提示其抗衰老潜力。进一步,通过YSM模型验证了奶牛尿液的血管生成活性。结论本研究为牛尿的无毒性提供了有力证据。我们的数据表明,牛尿的骨和软骨再生,抗衰老,血管生成和抗氧化性质表明其治疗价值。
{"title":"Beneficial effect of cow urine on stem cell differentiation, senescence, oxidative stress and angiogenesis in chick yolk sac model","authors":"Avinash Kharat,&nbsp;Swapnali Sakhare,&nbsp;Avinash Sanap,&nbsp;Pranjali Potdar,&nbsp;Supriya Kheur,&nbsp;Ramesh Bhonde","doi":"10.1016/j.jaim.2025.101194","DOIUrl":"10.1016/j.jaim.2025.101194","url":null,"abstract":"<div><h3>Background</h3><div>Cow urine has been utilized in traditional Indian medicine for the treatment of various ailments such as wounds, oxidative stress, and the management of various metabolic disorders with limited toxicity. However, there is a scarcity of scientific evidence confirming its exact mode of action.</div></div><div><h3>Objectives</h3><div>The aim of the study is to examine the mode of action of cow urine, also known as \"Gomutra\", focusing on its effect on human dental pulp stem cells (DPSCs) and chick yolk sac membrane (YSM) models.</div></div><div><h3>Material and methods</h3><div>DPSCs were isolated and characterised using a flow analyser, and used to assess the cytotoxicity, osteogenic and chondrogenic differentiation potential, anti-aging activity, anti-oxidative nature. Angiogenic potential was evaluated by YSM model.</div></div><div><h3>Results</h3><div>DPSCs showed fibroblast-like morphology and expressed mesenhymal stem cell markers viz., CD73, CD90, and CD105, and lacked expression of CD34, CD45 and HLA-DR. Our findings indicated that cow urine showed no toxicity at 1, 2, 4, 5, 10, 20 and 25% concentrations and promoted osteogenic and chondrogenic differentiation of DPSCs compared to standard controls. Additionally, cow urine effectively reduced oxidative stress and delayed cellular senescence in DPSCs, suggesting its anti-aging potential. Further, the study evidenced cow urine's angiogenic activity through YSM model.</div></div><div><h3>Conclusion</h3><div>This study provides substantial evidence for the non-toxic nature of cow urine. Our data demonstrates bone and cartilage regeneration, ant-aging, angiogenic and anti-oxidative nature of cow urine indicating its therapeutic value.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101194"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144534653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Mamsyadi Ghana capsule and Saraswatarista in the management of Insomnia Disorder - A Randomized Controlled Clinical Trial 加纳玛斯亚迪胶囊与沙参治疗失眠症的临床随机对照试验
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101160
M. Manasa , Aswini Padmashali , Basavaraj R. Tubaki , Manisha

Background

One of the prevalent sleep disorders is insomnia disorder. Current pharmacotherapy have limitations like dependence, tolerance and withdrawal effects. Ayurveda drugs remains to be explored.

Objectives

Can Ayurveda intervention (Mamsyadi Ghana Capsule and Saraswatharista) play a role in Insomnia disorder.

Material and Methods

50 patients meeting the diagnostic criteria of Insomnia Disorder (DSM 5), age group 20–70 years, either sex participated in the study. They were randomly divided and Ayurveda group received Mamsyadi Ghana Capsule 500 mg, Saraswatharista 10 ml, with equal quantity of water after food, both thrice a day for 30 days. Zolpidem group received tablet Zolpidem 10 mg once a day at bed time. Evaluations were done through Insomnia severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness scale (ESS), Sleep diary parameters, Depression Anxiety and Stress Scale (DASS), Quality of Life – SF 36 Questionnaire and UKU side effect rating scale. Clinical assessments were at baseline, 15th and 30th day.

Results

The study showed that Ayurveda intervention produced significant improvement and was comparable to Zolpidem. Both interventions were comparable in ISI, PSQI, ESS, DASS scale, sleep diary parameters and most of the components of SF-36. Role of limitations due to emotional problems component showed better improvement in Ayurveda group (p = 0.01). Within group analysis showed improvement in both the groups. Five patients had adverse effects with Zolpidem and nil with ayurveda group.

Conclusions

The study showed that effect of Ayurveda interventions (Mamsyadi Ghana Capsule and Saraswatharista) is comparable to zolpidem in Insomnia Disorder. Ayurveda intervention had better improvement on quality of life and had good safety profile.

Ctri registration number

CTRI/2021/12/038809.
背景失眠是常见的睡眠障碍之一。目前的药物治疗存在依赖性、耐受性和戒断效应等局限性。阿育吠陀药物仍有待探索。目的探讨阿育吠陀干预(Mamsyadi Ghana胶囊和saraswatharida)对失眠障碍的治疗作用。材料与方法50例符合失眠症诊断标准(DSM 5)的患者,年龄20 ~ 70岁,男女不限。随机分组,阿育吠陀组给予Mamsyadi Ghana胶囊500 mg, Saraswatharista 10 ml,餐后等量水,每天3次,连用30天。唑吡坦组患者给予唑吡坦片10 mg,每日1次,睡前服用。通过失眠严重程度指数(ISI)、匹兹堡睡眠质量指数(PSQI)、Epworth嗜睡量表(ESS)、睡眠日记参数、抑郁、焦虑和压力量表(DASS)、生活质量SF - 36问卷和UKU副作用评定量表进行评估。临床评估分别在基线、第15天和第30天进行。结果阿育吠陀干预治疗效果显著,与唑吡坦相当。两种干预措施在ISI、PSQI、ESS、DASS量表、睡眠日记参数和SF-36的大部分成分方面具有可比性。阿育吠陀治疗组因情绪问题导致的限制作用成分有较好的改善(p = 0.01)。组内分析显示两组均有改善。唑吡坦组不良反应5例,阿育吠陀组无不良反应。结论阿育吠陀治疗失眠症的效果与唑吡坦相当。阿育吠陀干预对患者的生活质量有较好的改善,且具有良好的安全性。Ctri注册号Ctri /2021/12/038809。
{"title":"Efficacy of Mamsyadi Ghana capsule and Saraswatarista in the management of Insomnia Disorder - A Randomized Controlled Clinical Trial","authors":"M. Manasa ,&nbsp;Aswini Padmashali ,&nbsp;Basavaraj R. Tubaki ,&nbsp;Manisha","doi":"10.1016/j.jaim.2025.101160","DOIUrl":"10.1016/j.jaim.2025.101160","url":null,"abstract":"<div><h3>Background</h3><div>One of the prevalent sleep disorders is insomnia disorder. Current pharmacotherapy have limitations like dependence, tolerance and withdrawal effects. Ayurveda drugs remains to be explored.</div></div><div><h3>Objectives</h3><div>Can Ayurveda intervention (<em>Mamsyadi Ghana</em> Capsule and <em>Saraswatharista</em>) play a role in Insomnia disorder.</div></div><div><h3>Material and Methods</h3><div>50 patients meeting the diagnostic criteria of Insomnia Disorder (DSM 5), age group 20–70 years, either sex participated in the study. They were randomly divided and Ayurveda group received <em>Mamsyadi Ghana</em> Capsule 500 mg, <em>Saraswatharista</em> 10 ml, with equal quantity of water after food, both thrice a day for 30 days. Zolpidem group received tablet Zolpidem 10 mg once a day at bed time. Evaluations were done through Insomnia severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness scale (ESS), Sleep diary parameters, Depression Anxiety and Stress Scale (DASS), Quality of Life – SF 36 Questionnaire and UKU side effect rating scale. Clinical assessments were at baseline, 15th and 30th day.</div></div><div><h3>Results</h3><div>The study showed that Ayurveda intervention produced significant improvement and was comparable to Zolpidem. Both interventions were comparable in ISI, PSQI, ESS, DASS scale, sleep diary parameters and most of the components of SF-36. Role of limitations due to emotional problems component showed better improvement in Ayurveda group (p = 0.01). Within group analysis showed improvement in both the groups. Five patients had adverse effects with Zolpidem and nil with ayurveda group.</div></div><div><h3>Conclusions</h3><div>The study showed that effect of Ayurveda interventions (<em>Mamsyadi Ghana</em> Capsule and <em>Saraswatharista</em>) is comparable to zolpidem in Insomnia Disorder. Ayurveda intervention had better improvement on quality of life and had good safety profile.</div></div><div><h3>Ctri registration number</h3><div>CTRI/2021/12/038809.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101160"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144572111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1